BD's outgoing diagnostic solutions and biosciences catalog brought in about $3.4 billion in 2024 sales. It will include tests for infectious disease and cervical cancer screening, as well as flow ...
BD, a leading global medical technology company, and Frazier Healthcare Partners, a leading private equity firm focused exclusively on the healthcare sector, announced a definitive agreement for BD to ...
Waters and BD shareholders are set to split ownership of the new outfit at about 60-40, respectively, while BD will also receive about $4 billion in cash. (Getty Images) BD has found a new home for ...
The CentroVena One system integrates essential components (including the guidewire, needle, syringe, and catheter) into a ...
BD (BDX), the MedTech firm also known as Becton, Dickinson, traded lower in the premarket on Monday despite posting better-than-expected financials for Q1 fiscal 2026, as its life sciences segment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results